Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scanfert Group is a Finland-based family investment company with roots in reproductive medicine and fertility clinic operations. The group was founded in Tampere in 1993, and its name derives from “Scandinavian” and “fertility,” reflecting its background in pioneering infertility treatment businesses. Today, Scanfert operates as a private equity-style investor with a health portfolio that includes fertility, gynecology, medical technology, and healthcare-related assets rather than a traditional drug development pipeline. Public materials also reference Scanfert Clinic and AVA Clinic Scanfert as fertility-service brands associated with the group’s historical clinic activities. For a biotech analyst, this is best characterized as a healthcare services and investment organization, not a biotech or pharma therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinic Scanfert.